Atea Pharmaceuticals Inc. – Indentures

NASDAQ: AVIR
Share price (4/8/26): $5.93
Market cap (4/8/26): $472 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended Atea Pharmaceuticals, Inc. Has One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended (The “Exchange Act”). References Herein to “We,” “US,” “Our” and the “Company” Refer to Atea Pharmaceuticals, Inc. General

from S-3ASR 51 pages Atea Pharmaceuticals, Inc. Indenture Dated as of , 20___ [ ] Trustee

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended

from S-8 7 pages Restated Certificate of Incorporation of Atea Pharmaceuticals, Inc

from S-8 3 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Atea Pharmaceuticals, Inc

from S-1/A 122 pages Atea Pharmaceuticals, Inc. Fourth Amended and Restated Stockholders Agreement

from S-1 2 pages Additional Abbreviations May Also Be Used Though Not in the Above List

from S-1 93 pages Atea Pharmaceuticals, Inc. Fourth Amended and Restated Stockholders Agreement

from DRS 93 pages Atea Pharmaceuticals, Inc. Fourth Amended and Restated Stockholders Agreement